BRTX · BioRestorative Therapies, Inc. · Investor Relations
$1.52
+0.01 (+0.66%)
At close · Nov 6
Return incl. dividend (before tax)
Q3 2025 earnings call transcript
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“we believe we do not have sufficient cash for at least twelve months after the issuance date of the financial statements included in this Quarterly Report which raises substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$1.92M
Shares
1.27M
Volume · Nov 6
11.92K
Avg daily vol (43 sessions)
33.6K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-09-02 | BioRestorative Therapies Announces Reverse Stock Split |
| 2026-02-17 | BioRestorative Announces Closing of $5.0 Million Public Offering |
| 2026-02-17 | BioRestorative Announces Pricing of $5.0 Million Public Offering |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-05-26 | Special Meeting of Stockholders | Shareholder meeting |
| 2026-05-06 | International Society for Cell & Gene Therapy (ISCT) 2026 Annual Meeting | Shareholder meeting |
| 2026-03-31 | 2026 Orthopaedic Research Society Annual Meeting | Shareholder meeting |
Source: https://ir.biorestorative.com/